Susan G Komen  
I've Been Diagnosed With Breast Cancer Someone I Know Was Diagnosed Share Your Story Join Us And Stay Informed Donate To End Breast Cancer
Home > Understanding Breast Cancer > Breast Facts > Breast Cancer Facts and Statistics References

  


Breast Cancer Facts and Statistics References

 

  1. Rosen PP. Rosen’s Breast Pathology. Philadelphia: Lippincott Williams & Wilkins, 2001.
  2. Osborne MP and Boolbol SK. Chapter 1. Breast anatomy and development, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  3. Smith RA, D’Orsi C, Newell MS. Chapter 11. Screening for breast cancer, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  4. Dillon DA, Guidi AJ, Schnitt SJ. Chapter 28: Pathology of Invasive Breast Cancer, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition, Lippincott Williams & Wilkins, 2010.
  5. Centers for Disease Control and Prevention. Breast cancer - what are the symptoms? http://www.cdc.gov/cancer/breast/basic_info/symptoms.htm, 2013.
  6. National Cancer Institute. General information about breast cancer. http://www.cancer.gov/cancertopics/pdq/treatment/breast/Patient, 2013
  7. American Cancer Society. Signs and symptoms of breast cancer. http://www.cancer.org/Cancer/BreastCancer/MoreInformation/BreastCancerEarlyDetection/breast-cancer-early-detection-signs-symptoms-br-ca, 2013.
  8. Sabel MS and Collins LC. Atypia and lobular carcinoma in situ: high risk lesions of the breast. In: Chagpar AB, ed. UpToDate. Waltham, MA, UpToDate, 2014.
  9. Bagaria SP, Shamonki J, Kinnaird M, Ray PS, Giuliano AE. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Ann Surg Oncol. 18(7):1845-51, 2011.
  10. Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol. 19(10):3131-8, 2012.
  11.  National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: Breast cancer screening and diagnosis. Version 2.2013. http://www.nccn.org, 2013.
  12. American Cancer Society. American Cancer Society recommendations for early breast cancer detection in women without breast symptoms. http://www.cancer.org/cancer/breastcancer/moreinformation/breastcancerearlydetection/breast-cancer-early-detection-acs-recs, 2014.
  13. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: Breast cancer risk reduction. Version 1.2013. http://www.nccn.org, 2013.
  14. Vogel VG, Costantino JP, Wickerham DL, et al. for the National Surgical Adjuvant Breast and Bowel Project. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res. 3(6):696-706, 2010.
  15. Goss PE, Ingle JN, Alés-Martínez JE, et al. for the NCIC CTG MAP.3 Study Investigators. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med. 364(25):2381-91, 2011.
  16. Rohan TE, Negassa A, Chlebowski RT, et al. Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol Biomarkers Prev. 17(9):2337-43, 2008.
  17. Rohan TE, Negassa A, Chlebowski RT, et al. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 100(8):563-71, 2008.
  18. Bertelsen L, Mellemkjaer L, Balslev E, Olsen JH. Benign breast disease among first-degree relatives of young breast cancer patients. Am J Epidemiol. 168(3):261-7, 2008.
  19. Cui Y, Page DL, Lane DS, Rohan TE. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study. Breast Cancer Res Treat. 114(1):113-20, 2009.
  20. Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer. 118(11):2796-803, 2012.
  21. Cui Y, Page DL, Chlebowski RT, et al. Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast. Int J Cancer. 121(6):1346-51, 2007.
  22. Berkey CS, Willett WC, Frazier AL, et al. Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics. 125(5):e1081-7, 2010.
  23. Liu Y, Tamimi RM, Berkey CS, et al. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 129(5):e1192-8, 2012.
  24. Liu Y, Colditz GA, Rosner B, et al. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst. 105(20):1571-8, 2013.
  25. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 353(3):229-37, 2005.
  26. Laronga C, Tollin S, Thurlow M. Breast cysts-clinical manifestations, diagnosis and management. In: Chagpar AB, ed. UpToDate. Waltham, MA, UpToDate, 2014.
  27. Webb PM, Byrne C, Schnitt SJ, et al. A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev. 13(7):1106-13, 2004.
  28. Sabel MS. Overview of benign breast disease. In: Chagpar AB, ed. UpToDate. Waltham, MA, UpToDate, 2014.
  29. Schnitt SJ and Collins LC. Chapter 10. Pathology of benign breast disorders, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  30. National Cancer Institute. Understanding breast changes: a health guide for women. http://www.cancer.gov/cancertopics/screening/understanding-breast-changes, 2012.
  31. Kabat GC, Jones JG, Olson N, et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control. 21(6):821-8, 2010.
  32. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med. 340(6):430-6, 1999.
  33. Santen RJ, Mansel MD. Benign breast disorders. N Engl J Med. 353(3):275-85, 2005.
  34. Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD. Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer. 106(7):1453-61, 2006.
  35. Berg JC, Visscher DW, Vierkant RA, et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 108(2):167-74, 2008.
  36. Aroner SA, Collins LC, Connolly JL, et al. Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies. Breast Cancer Res Treat. 139(1):277-85, 2013.
  37. American Cancer Society. Cancer Facts and Figures 2014. Atlanta, GA: American Cancer Society, 2014.
  38. Siegel R, Ma J, Zou Z, Jemal A. Cancer Statistics, 2014. CA Cancer J Clin. 64(1):9-29, 2014.
  39. Howlader N, Noone AM, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2010: Fast Stats. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2010/, 2013.
  40. National Cancer Institute. Male breast cancer treatment. http://www.cancer.gov/cancertopics/pdq/treatment/malebreast, 2013.
  41. American Cancer Society. Breast Cancer Facts and Figures 2013-2014. Atlanta, GA: American Cancer Society, 2013.
  42. Kerlikowske K, Miglioretti DL, Buist DSM, Walker R, Carney PA for the National Cancer Institute-Sponsored Breast Cancer Surveillance Consortium. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 99(17):1335-9, 2007.
  43. Chlebowski RT, Kuller LH, Prentice RL, et al. for the WHI Investigators. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 5;360(6):573-87, 2009.
  44. International Agency for Research on Cancer (IARC) and World Health Organization (WHO). GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx, 2014.
  45. Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 378(9801):1461-84, 2011.
  46. American Cancer Society. Cancer Facts and Figures for African Americans 2013-2014. Atlanta, GA: American Cancer Society, 2013.
  47. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures, 2013. American Cancer Society, 2013.
  48. National Cancer Institute. Genetics of breast and ovarian cancer (PDQ). http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional, 2013.
  49. Thorlacius S, Struewing JP, Hartge P, et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet. 352: 1337-9, 1998.
  50. Antoniou A, Pharoah PDP, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 72(5):1117-30, 2003.
  51. King MC, Marks JH and Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 302: 643-6, 2003.
  52. Risch HA, McLaughlin JR, Cole DEC, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 98(23):1694-706, 2006.
  53. John EM, Miron A, Gong G, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA. 298 (24): 2869-76, 2007.
  54. Malone KE, Daling JR, Doody DR, et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res. 66 (16): 8297-308, 2006.
  55. Yi M, Liu P, Li X, et al. Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer. 118(17):4117-25, 2012.
  56. American Cancer Society. Cancer Facts and Figures for Hispanics/Latinos, 2012-2014. Atlanta, GA: American Cancer Society, 2013.
  57. Wingo PA, King J, Swan J, et al. Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004. Cancer. 113(5 Suppl):1191-202, 2008.
  58. Case P, Austin SB, Hunter DJ, et al. Sexual orientation, health risk factors, and physical functioning in the Nurses' Health Study II. J Womens Health (Larchmt). 13(9):1033-47, 2004.
  59. Zaritsky E, Dibble SL. Risk factors for reproductive and breast cancers among older lesbians. J Womens Health (Larchmt). 19(1):125-31, 2010.
  60. Austin SB, Pazaris MJ, Rosner B, Bowen D, Rich-Edwards J, Spiegelman D. Application of the Rosner-Colditz risk prediction model to estimate sexual orientation group disparities in breast cancer risk in a U.S. cohort of premenopausal women. Cancer Epidemiol Biomarkers Prev. 21(12):2201-8, 2012.
  61. Boehmer U, Miao X, Linkletter C, Clark MA. Adult health behaviors over the life course by sexual orientation. Am J Public Health. 102(2):292-300, 2012.
  62. Cochran SD, Mays VM. Risk of breast cancer mortality among women cohabiting with same sex partners: findings from the national health interview survey, 1997-2003. J Womens Health (Larchmt). 21(5):528-33, 2012.
  63. Austin SB, Pazaris MJ, Nichols LP, Bowen D, Wei EK, Spiegelman D. An examination of sexual orientation group patterns in mammographic and colorectal screening in a cohort of U.S. women. Cancer Causes Control. 24(3):539-47, 2013.
  64. Brandenburg DL, Matthews AK, Johnson TP, Hughes TL. Breast cancer risk and screening: a comparison of lesbian and heterosexual women. Women Health. 45(4):109-30, 2007.
  65. Hart SL, Bowen DJ. Sexual orientation and intentions to obtain breast cancer screening. J Womens Health (Larchmt). 18(2):177-85, 2009.
  66. Litton JK, Theriault RL. Chapter 68. Breast cancer during pregnancy and subsequent pregnancy in breast cancer survivors, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.Wisinski KB and Gradishar WJ. Chapter 64: Male Breast Cancer. In Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 34thrd edition. Lippincott, Williams and Wilkins, 2010.
  67. American Society of Clinical Oncology. Breast cancer – male. http://www.cancer.net/cancer-types/breast-cancer-male, 2010.
  68. Gradishar WJ. Breast cancer in men. In: Hayes DF and Chagpar AB, eds. UpToDate. Waltham, MA, UpToDate, 2014.
  69. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 101(1):51-7, 2004.
  70. Chavez-Macgregor M, Clarke CA, Lichtensztajn D, Hortobagyi GN, Giordano SH. Male breast cancer according to tumor subtype and race: A population-based study. Cancer. 119(9):1611-7, 2013.
  71. Niewoehner CB, Schorer AE. Gynaecomastia and breast cancer in men. BMJ. 336(7646):709-13, 2008.
  72. Brinton LA, Carreon JD, Gierach GL, McGlynn KA, Gridley G. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat. 119(1):185-92, 2010.
  73. Brinton LA, Cook MB, McCormack V, et al. Anthropometric and hormonal risk factors for male breast cancer: Male Breast Cancer Pooling Project results. J Natl Cancer Inst. 2014 Feb 19. [Epub ahead of print].
  74. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 367(9510):595-604, 2006.
  75. Thorlacius S, Sigurdsson S, Bjarnadottir H, et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet. 60(5): 1079–1084, 1997.
  76. Tai YC, Domchek S, Parmigiani G, Chen S. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 99(23):1811-4, 2007.
  77. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 25(11):1329-33, 2007.
  78. Orr N, Lemnrau A, Cooke R, et al. Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat Genet. 44(11):1182-4, 2012.  

Updated 03/15/14 

 previous 

Breast Cancer Statistics 

Breast Cancer Facts and
Statistics Home

 010674.gif